ImmunoPrecise Antibodies's market cap is currently ―. The company's EPS TTM is C$; its P/E ratio is ―; ImmunoPrecise Antibodies is scheduled to report earnings on October 3, 2023, and the estimated EPS forecast is C$-0.20. See an overview of income statement, balance sheet, and cash flow financials.

	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22
Income Statement	-
Total Revenue	C$ 5.62M	C$ 5.17M	-	C$ 4.69M	C$ 5.24M
Gross Profit	C$ 3.34M	C$ 2.96M	-	C$ 2.48M	C$ 3.32M
EBIT	C$ -5.94M	C$ -4.63M	-	C$ -9.73M	C$ -4.27M
EBITDA	C$ -3.96M	-	-	C$ -8.18M	C$ -3.35M
Net Income Common Stockholders	C$ -5.13M	C$ -4.70M	-	C$ -9.38M	C$ -4.64M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 8.28M	C$ 11.32M	-	C$ 19.24M	C$ 29.96M
Total Assets	C$ 77.81M	C$ 82.44M	-	C$ 79.94M	C$ 93.49M
Total Debt	C$ 7.27M	C$ 7.47M	C$ 0.00	C$ 1.12M	C$ 2.55M
Net Debt	C$ -1.01M	C$ -3.85M	C$ 0.00	C$ -18.12M	C$ -27.42M
Total Liabilities	C$ 20.01M	C$ 21.36M	-	C$ 13.70M	C$ 18.21M
Stockholders Equity	C$ 57.80M	C$ 61.08M	-	C$ 66.24M	C$ 75.28M
Cash Flow	-
Free Cash Flow	C$ -2.70M	C$ -18.63M	-	C$ -10.40M	C$ -2.12M
Operating Cash Flow	C$ -2.23M	C$ -17.60M	-	C$ -10.31M	C$ -1.79M
Investing Cash Flow	C$ -444.00K	C$ -1.52M	-	C$ -89.00K	C$ -4.09M
Financing Cash Flow	C$ -381.00K	C$ -240.00K	-	C$ -152.00K	C$ 3.06M

Currency in CAD

ImmunoPrecise Antibodies Earnings and Revenue History

Income Statement >

ImmunoPrecise Antibodies Debt to Assets

Balance Sheet >

ImmunoPrecise Antibodies Cash Flow

Cash Flow >

ImmunoPrecise Antibodies Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing